[ORGANIZATION]
Disitamab Vedotin
Featured in 1 tracked story · first seen
Situations
Advancements in lung and breast cancer clinical trials
2 clusters · 13 sources · last updated
Latest: HER2-targeted antibody-drug conjugates show positive Phase III trial results
Recent clinical trial data presented at the IASLC 2026 World Conference on Lung Cancer and in the Journal of Clinical Oncology highlight significant advancements in oncology treatments, particularly regarding antibody-dr